A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity.
- 2023-05-10
- Review
- Cancer cell international 23(1)
- Mandeep Singh
- Mustafa M Kadhim
- Abduladheem Turki Jalil
- Shamam Kareem Oudah
- Zafar Aminov
- Fahad Alsaikhan
- Zanko Hassan Jawhar
- Andrés Alexis Ramírez-Coronel
- Bagher Farhood
- PubMed: 37165384
- DOI: 10.1186/s12935-023-02936-4
- Low evidence
bradycardia... these echocardiographic abnormalities were obviously improved in the silymarin plus doxorubicin groups.
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes